ISRCTN13199265已完成未知
The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial
niversity clinical center of Republika Srpska0 个研究点目标入组 66 人开始时间: 2021年4月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 66
研究概览
简要总结
2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34665453/ (added 20/10/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Polycystic Ovary Syndrome, diagnosed in accordance with Rotterdam Consensus Conference Criteria 2003
- •2. Age 18 - 40 years
排除标准
- •1. Significant liver or renal impairment
- •2. Other hormonal dysfunction (hypothalamic, pituitary, thyroidal or adrenal causes for the clinical signs)
- •3. History of drug and alcohol abuse
- •4. History of breast and uterine cancer
- •5. Diagnosis of diabetes mellitus
- •6. Use of drugs able to interfere with gluco-insulinaemic metabolism for at least three months prior to entering the study
研究者
相似试验
进行中(未招募)
1 期
The effect of myoinositol (MI) or metformin treatment on symptoms of polycystisk ovary syndrome (PCOS), including metabolism, menstrual pattern, quality of life and mental health.Polycystic ovarian syndrome (PCOS)MedDRA version: 19.1Level: LLTClassification code 10065161Term: Polycystic ovarian syndromeSystem Organ Class: 100000004872EUCTR2016-004506-34-DKOdense Universitetshospital40
Unknown
早期 1 期
Comparison of Myoinositol and Metformin in PCOPCOSNCT04204044Rashid Latif Medical College126
尚未招募
不适用
Myoinositol a new treatment option in Polycystic Ovarian Syndrome versus metformin-the conventional drug.CTRI/2019/09/021403Swati Jain
已完成
2 期
The effects of MYO- Inositol and metformin on oxidative stress and homocysteine levels in patients with polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovary syndromeE28.2IRCT20190508043516N1Dezfoul University of Medical Sciences40
终止
1 期
Metabolic Effects of Metformin Therapy in Obstructive Sleep ApneaSleep Apnea, ObstructiveNCT04530747Pennington Biomedical Research Center16
